Literature DB >> 26376671

Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.

Teruhiko Imamura1, Koichiro Kinugawa, Daisuke Nitta, Issei Komuro.   

Abstract

BACKGROUND: We previously reported that cardiac resynchronization therapy with defibrillator (CRT-D) is not an appropriate rescue strategy in patients with advanced heart failure (HF), especially those dependent on inotrope infusion, and instead early ventricular assist device (VAD) implantation should be considered. Predictors of response to CRT in such populations, however, remain uncertain. METHODS AND 
RESULTS: We studied 67 inpatients aged <65 years old with advanced HF, who received CRT-D between 2007 and 2014. Eleven patients (16%) were responders, in whom LVEF improved >10% at 6-month follow up. On logistic regression analysis, LA volume index (LAVI) <43 ml/m(2)(odds ratio (OR), 36.67; P=0.001) and complete left bundle branch block (CLBBB; OR, 6.663; P=0.032) were significant predictors of response to CRT-D among the baseline variables. Patients with both predictors were associated with improvements in LVEF and plasma B-type natriuretic peptide compared with those with none of these predictors during the 6-month follow up period (P<0.05 for both). VAD-free survival rate was significantly higher in the responders compared with the non-responders during the 2-year study period (86% vs. 52%, P=0.044).
CONCLUSIONS: CLBBB and smaller LAVI are novel predictors of response in patients with advanced HF receiving CRT-D in real-world practice. Such responders may be better candidates for CRT-D and delay of cardiac replacement therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26376671     DOI: 10.1253/circj.CJ-15-0769

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

Review 1.  Left atrial volume index predicts response to cardiac resynchronisation therapy: a systematic review and meta-analysis.

Authors:  Ibadete Bytyçi; Gani Bajraktari; Michael Y Henein
Journal:  Arch Med Sci       Date:  2020-01-10       Impact factor: 3.707

Review 2.  Indication of Ventricular Assist Device Therapy in Patients with INTERMACS Profile 4-7.

Authors:  Teruhiko Imamura; Koichiro Kinugawa
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-06-27       Impact factor: 1.520

3.  Effect of cardiac resynchronization therapy on mitral valve geometry: a novel aspect as "reversed mitral remodeling".

Authors:  Oguz Karaca; Beytullah Cakal; Mehmet Onur Omaygenc; Haci Murat Gunes; Filiz Kizilirmak; Sinem Deniz Cakal; Deniz Dilan Naki; Irfan Barutcu; Bilal Boztosun; Fethi Kilicaslan
Journal:  Int J Cardiovasc Imaging       Date:  2018-01-31       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.